Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Outcomes of FOLFIRINOX and gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after adjuvant S-1: A propensity score–matching analysis.
Authors
Naohiro Okano
Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan;
Naohiro Okano , Kentaro Sakamaki , Takafumi Mie , Kazuo Watanabe , Satoshi Kobayashi , Akiko Todaka , Yuko Suzuki , Hidetoshi Kitamura , Kazunari Tanaka , Kei Nakagawa , Keiko Kamei , Kumiko Umemoto , Nobuaki Azemoto , Yasuyuki Kawamoto , Hiroaki Yanagimoto , Kunihiro Tsuji , Hiroshi Imaoka , Takeshi Terashima , Makoto Ueno , Junji Furuse
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 707)
DOI
10.1200/JCO.2023.41.4_suppl.707
Abstract #
707
Poster Bd #
K14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy of sequential perioperative FOLFIRNOX plus gemcitabine nab-paclitaxel for resected pancreatic and periampullary cancers.
First Author: Putao Cen
Poster
2021 Gastrointestinal Cancers Symposium
Efficacy and safety of 5-fluorouracil (5-FU) / levofolinate / irinotecan (FOLFIRI) for previously treated advanced pancreatic cancer (APC).
First Author: Hiromichi Shirasu
Poster
2020 ASCO Virtual Scientific Program
FOLFIRINOX de-escalation in advanced pancreatic cancer (aPC): A multicenter real-life study.
First Author: Hortense Chevalier
Poster
2020 Gastrointestinal Cancers Symposium
Real-world patterns of care among patients with metastatic pancreatic cancer (mPC).
First Author: Eileen Mary O'Reilly